Loading
Latest filing published 05 Jan 2026 for Compass Therapeutics, Inc., €550k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Barry Shin across 2 companies, led by Trevena Inc and Compass Therapeutics, Inc. We count 18 filings; the first trade dates from 25 June 2021 and the latest from 2 January 2026.
Every open-market trade on record is a sale: 1 sale. The amount is not disclosed for 1 filing. Besides market trades, the filings include 17 share grants.
The newest entry dates from 5 January 2026: a share grant of €550k, in Compass Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations